Chris Farley
About Chris Farley
Chris Farley is an Associate Research Scientist at Bristol Myers Squibb in Lawrenceville, New Jersey, specializing in organic chemistry research.
Current Role at Bristol Myers Squibb
Chris Farley is currently an Associate Research Scientist at Bristol Myers Squibb, stationed in Lawrenceville, New Jersey. He joined the company in October 2018 and has contributed to various research projects within the pharmaceutical industry. Farley's expertise in organic chemistry supports his role in the company's research and development division, focusing on innovative solutions and advancements in medicine.
Previous Experience at The University of Texas at Austin
Before joining Bristol Myers Squibb, Chris Farley served as a Graduate Research Assistant at The University of Texas at Austin from 2014 to 2018. During his tenure, he engaged in extensive research in organic chemistry, contributing to academic publications and laboratory projects. This role helped him develop a strong foundation in research methodologies and practices, facilitating his transition into the pharmaceutical industry.
Educational Background in Chemistry and Biology
Chris Farley earned his Master of Science degree in Organic Chemistry from The University of Texas at Austin, completing the program between 2014 and 2018. Prior to this, he obtained a Bachelor of Science degree in Chemistry and Biology from William & Mary, where he studied from 2010 to 2014. His academic background combines rigorous training in both chemistry and biology, equipping him with a solid foundation to excel in research environments.
Industry and Academic Research Experience
Chris Farley has garnered over 5 years of experience in the pharmaceutical industry, specializing in organic chemistry research. His career encompasses significant roles in both academic settings and industrial research. At The University of Texas at Austin, he developed a keen understanding of fundamental research practices, which he has since applied in his current role at Bristol Myers Squibb, contributing to the development of pharmaceutical solutions.